Displaying results 1 - 12 of 142
General Hepatology

Final results of MYR301: a randomised phase 3 study evaluating the efficacy and safety of up to 144 weeks of bulevirtide monot...

Webcasts
View
General Hepatology

High prevalence of undiagnosed liver fibrosis in the adult european population driven by metabolic risk factors and alcohol co...

Webcasts
View
General Hepatology

Belapectin at 2 mg/kg/LBW reduces varices development in MASH cirrhosis with portal hypertension: results from the NAVIGATE tr...

Webcasts
View
Viral Hepatitis

Clinical Practice Guidelines: HBV (Complete Session)

Webcasts
View
General Hepatology

Late Breaker (Complete Session)

Webcasts
View
General Hepatology

Congress Highlights (Complete Session)

Webcasts
View
General Hepatology

Global Liver Forum: Tailored Approaches to Hepatic Encephalopathy Worldwide (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

AKH Inc., Advancing Knowledge in Healthcare: A New Era in MASH: How Disease-Specific Therapies Are Changing the Game and Best ...

Webcasts
View
General Hepatology

Clinical Practice Guidelines: AIH and eCCA (Complete Session)

Webcasts
View
Viral Hepatitis

EASL Studio: The unmet needs in viral hepatitis (Complete Session)

Webcasts
View
General Hepatology

Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and ...

Webcasts
View
General Hepatology

Efficacy and safety of long-term human albumin therapy in cirrhotic patients with acute decompensation and ascites: top-line r...

Webcasts
View
Displaying results 1 - 12 of 142